CVSH34 Stock Overview
CVS Health Corporation provides health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$34.89 |
| 52 Week High | US$40.43 |
| 52 Week Low | US$32.14 |
| Beta | 0.51 |
| 1 Month Change | -11.80% |
| 3 Month Change | -1.99% |
| 1 Year Change | -4.25% |
| 3 Year Change | -14.81% |
| 5 Year Change | 56.49% |
| Change since IPO | -3.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSH34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -4.3% | 3.8% | 0.4% |
| 1Y | -4.3% | 3.9% | 13.9% |
Return vs Industry: CVSH34 underperformed the BR Healthcare industry which returned 5.2% over the past year.
Return vs Market: CVSH34 underperformed the BR Market which returned 14.9% over the past year.
Price Volatility
| CVSH34 volatility | |
|---|---|
| CVSH34 Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: CVSH34 has not had significant price volatility in the past 3 months.
Volatility Over Time: CVSH34's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVSH34 fundamental statistics | |
|---|---|
| Market cap | R$439.71b |
| Earnings (TTM) | R$42.95b |
| Revenue (TTM) | R$1.84t |
10.2x
P/E Ratio0.2x
P/S RatioIs CVSH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSH34 income statement (TTM) | |
|---|---|
| Revenue | US$356.62b |
| Cost of Revenue | US$303.35b |
| Gross Profit | US$53.28b |
| Other Expenses | US$44.93b |
| Earnings | US$8.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 6.62 |
| Gross Margin | 14.94% |
| Net Profit Margin | 2.34% |
| Debt/Equity Ratio | 78.6% |
How did CVSH34 perform over the long term?
See historical performance and comparison